Composition
- Active ingredients
- TERAZOSIN HYDROCHLORIDE EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TERAZOSIN HYDROCHLORIDE EQ 10MG BASE · TabletNDA019057-004 · Discontinued
- TERAZOSIN HYDROCHLORIDE EQ 2MG BASE · TabletNDA019057-002 · Discontinued
- TERAZOSIN HYDROCHLORIDE EQ 5MG BASE · TabletNDA019057-003 · Discontinued
- TERAZOSIN HYDROCHLORIDE EQ 1MG BASE · TabletNDA019057-001 · Discontinued
- TERAZOSIN HYDROCHLORIDE EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA020347-003 · Discontinued
- TERAZOSIN HYDROCHLORIDE EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA020347-001 · Discontinued
- TERAZOSIN HYDROCHLORIDE EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA020347-004 · Discontinued
- TERAZOSIN HYDROCHLORIDE EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleThis page
Official product information
At a glance
- Brand name
- Hytrin
- Active substance
- terazosin hydrochloride
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Abbott
- Status
- Discontinued
- FDA approval
- 14 Dec 1994
- Application
- NDA020347-002